NASDAQ
Akero Therapeutics, Inc. (AKRO) has a current ratio of 19.38x as of Monday, May 25, 2026. This represents a 1.61% increase compared to its 12-month average of 19.07x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.